CGIX - Cancer Genetics Stock Trading
Cancer Genetics Inc.(NASDAQ: CGIX) stock trading description contact officers and directors.
About Cancer Genetics Inc.
We are a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer theranosis . Our proprietary tests target cancers where prognosis information is critical and where predicting treatment outcomes using currently available techniques is limited. These cancers include ematological, urogenital and HPV associated cancers. We have commercially launched MatBA CLL and SLL, our first proprietary microarray diagnostic tests, and seek to provide our tests and services to oncologists and pathologists at hospitals, cancer centers and physician offices, as well as to biopharmaceutical companies and clinical research organizations for their clinical trials.
Stock Information
Get CGIX Alerts
News, Short Squeeze, Breakout and More Instantly...